Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis
Phase 2
Not yet recruiting
- Conditions
- Psoriasis
- Interventions
- Drug: 5% GM-XANTHO [GM-XAN003]Drug: Placebo
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Xantho Biotechnology Co., LTD
- Target Recruit Count
- 65
- Registration Number
- NCT06620692
A Study of GM-XANTHO in Pressure Ulcer Patients
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Xantho Biotechnology Co., LTD
- Target Recruit Count
- 58
- Registration Number
- NCT05199077
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Placebo onitmentDrug: GM-XANTHO onitment
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Xantho Biotechnology Co., LTD
- Target Recruit Count
- 76
- Registration Number
- NCT04369846
- Locations
- 🇨🇳
Ministry of Health and Welfare Shuang-Ho Hospital, New Taipei, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
News
No news found